In Vitro Activities of Azithromycin and Ofloxacin againstChlamydia pneumoniaein a Continuous-Infection Model
- 1 September 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (9) , 2268-2272
Abstract
Chlamydia pneumoniaeis a well-established cause of community-acquired pneumonia and bronchitis in adults and children. Chronic infections withC. pneumoniaehave been implicated in the development of atherosclerosis and other diseases in humans. Methods currently used for the culture and propagation ofC. pneumoniaeare not analogous to the infection as it occurs in vivo. We have established a model of continuousC. pneumoniaeinfection in vitro. HEp-2 cells inoculated with CM-1 and TW-183 strains have been persistently infected for periods of over 1.5 and 2 years, respectively. The cultures were maintained without centrifugation or the addition of cycloheximide, fresh host cells, or chlamydia. We observed cycles of host cell lysis, detachment, and regrowth with both strains ofC. pneumoniae. ContinuousC. pneumoniaeinfections may more closely resemble the actual events as they occur in vivo and, therefore, may be a better model for the in vitro study ofC. pneumoniaeinfection. When we used continuously infected cells to determine the effects of azithromycin and ofloxacin onC. pneumoniaepropagation in vitro, we found that both drugs reduced but did not completely eliminate the organism. This may be an important observation, as the failure of antibiotic therapy againstC. pneumoniaeinfection in humans has been described.Keywords
This publication has 14 references indexed in Scilit:
- Chlamydia pneumoniae stimulates production of IL-4 and IL-6 in HEp-2 cells. † 757Pediatric Research, 1997
- Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary ArteriesThe Journal of Infectious Diseases, 1993
- In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1992
- In vitro activities of five quinolones against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1992
- Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart StudyAnnals of Internal Medicine, 1992
- Persistent Infection with Chlamydia pneumoniae following Acute Respiratory IllnessClinical Infectious Diseases, 1992
- Spread and Persistence of Infection with a Trachoma Biovar Strain of Chlamydia trachomatis in Multiplying and Nonmultiplying McCoy CellsSexually Transmitted Diseases, 1990
- Serial changes in virus and cells in cultures chronically infected with psittacosis virusVirology, 1961
- Effect of Antiserum and Antibiotics on Persistent Infection of HeLa Cells with Meningopneumonitis VirusThe Journal of Immunology, 1961
- Persistent Infection of HeLa Cells with Meningopneumonitis VirusThe Journal of Immunology, 1959